Crinetics Pharmaceuticals Inc (CRNX)
57.00
+0.93
(+1.66%)
USD |
NASDAQ |
Nov 21, 16:00
57.00
0.00 (0.00%)
After-Hours: 16:06
Crinetics Pharmaceuticals Market Cap: 5.286B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 5.200B |
| November 19, 2024 | 5.116B |
| November 18, 2024 | 4.980B |
| November 15, 2024 | 5.075B |
| November 14, 2024 | 5.533B |
| November 13, 2024 | 5.464B |
| November 12, 2024 | 5.451B |
| November 11, 2024 | 5.565B |
| November 08, 2024 | 5.628B |
| November 07, 2024 | 5.523B |
| November 06, 2024 | 5.463B |
| November 05, 2024 | 5.338B |
| November 04, 2024 | 5.247B |
| November 01, 2024 | 5.235B |
| October 31, 2024 | 5.167B |
| October 30, 2024 | 5.149B |
| October 29, 2024 | 5.195B |
| October 28, 2024 | 5.277B |
| October 25, 2024 | 5.352B |
| October 24, 2024 | 5.424B |
| October 23, 2024 | 5.393B |
| October 22, 2024 | 5.504B |
| October 21, 2024 | 5.420B |
| October 18, 2024 | 5.456B |
| October 17, 2024 | 5.441B |
| Date | Value |
|---|---|
| October 16, 2024 | 5.435B |
| October 15, 2024 | 5.319B |
| October 14, 2024 | 4.903B |
| October 11, 2024 | 4.907B |
| October 10, 2024 | 4.781B |
| October 09, 2024 | 4.099B |
| October 08, 2024 | 4.179B |
| October 07, 2024 | 4.184B |
| October 04, 2024 | 4.296B |
| October 03, 2024 | 4.266B |
| October 02, 2024 | 4.367B |
| October 01, 2024 | 4.197B |
| September 30, 2024 | 4.131B |
| September 27, 2024 | 4.062B |
| September 26, 2024 | 4.048B |
| September 25, 2024 | 4.038B |
| September 24, 2024 | 3.987B |
| September 23, 2024 | 4.035B |
| September 20, 2024 | 4.254B |
| September 19, 2024 | 4.312B |
| September 18, 2024 | 4.223B |
| September 17, 2024 | 4.241B |
| September 16, 2024 | 4.317B |
| September 13, 2024 | 4.306B |
| September 12, 2024 | 4.100B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
283.01M
Minimum
Mar 16 2020
5.628B
Maximum
Nov 08 2024
1.414B
Average
953.84M
Median
Feb 16 2022
Market Cap Benchmarks
| Clearside Biomedical Inc | 78.12M |
| Biomea Fusion Inc | 231.57M |
| NovaBay Pharmaceuticals Inc | 3.508M |
| Palatin Technologies Inc | 17.79M |
| iBio Inc | 22.42M |
Market Cap Related Metrics
| PEG Ratio | -1.390 |
| Price to Book Value | 6.346 |
| Price | 57.00 |
| Earnings Yield | -6.54% |
| PEGY Ratio | -1.390 |